Carotid plaque thickness predicts cardiovascular events and death in patients with chronic kidney disease

Sasha S Bjergfelt1,2, Ida M H Sørensen1, Laerke Urbak3

  • 1Department of Nephrology, Rigshospitalet, University of Copenhagen, Blegdamsvej 9, Copenhagen, DK-2100, Denmark.

BMC Nephrology
|November 1, 2024
PubMed

Insights

Maximal carotid plaque thickness (cPTmax) can predict major adverse cardiovascular events (MACE) in chronic kidney disease (CKD) patients. cPTmax demonstrated a similar predictive ability for MACE as coronary artery calcium score (CACS) in this population.

Area of Science:

  • Cardiology
  • Nephrology
  • Vascular Imaging

Background:

  • Classical cardiovascular risk scores underestimate risk in chronic kidney disease (CKD).
  • Coronary artery calcium score (CACS) improves cardiovascular event prediction in CKD.
  • Maximal carotid plaque thickness (cPTmax) shows predictive value similar to CACS in the general population.

Purpose of the Study:

  • Investigate cPTmax's ability to predict cardiovascular events in CKD patients.
  • Compare the predictive value of cPTmax and CACS in CKD.

Main Methods:

  • Ultrasound assessment of cPTmax in 200 CKD stage 3 patients.
  • Categorization of patients based on cPTmax: No plaques, 1.0-1.9 mm, and >1.9 mm.
  • CACS measured in 175 patients via non-contrast CT scan.
  • Follow-up for major adverse cardiovascular events or death (MACE).

Main Results:

  • 45 patients (22.5%) experienced MACE over a median 5.4-year follow-up.
  • Patients with cPTmax >1.9 mm had a significantly increased hazard ratio for MACE (HR 3.2).
  • Models including cPTmax or CACS showed similar improvements in predicting MACE (C-statistics 0.247 vs. 0.243).

Conclusions:

  • cPTmax is a potentially useful tool for predicting MACE in CKD.
  • cPTmax and CACS exhibit comparable abilities in predicting MACE within the CKD population.
Abstract

Related Concept Videos

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
3
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
61
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
57